
EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
This month, ADI staff and representatives took part in important activity in the European region. ADI Regional Director for the Americas, Diego Aguilar, travelled to Madrid to attend the Triangular Cooperation Seminar, organised by the European Union's ADELANTE 2 Programme. ADI Head of Membership, Laura Aubert, visited ADI’s member in Czechia and attended the 19th World Congress on Controversies in Neurology in Prague. Then, ADI staff attended the World Dementia Council meeting in London for the 2025 Summit. We round off this blog by celebrating the co-founder of ADI’s member in Russia, Alzrus, Alexandra Shchetkina, for her nomination for the most prestigious Russian educational award - the Knowledge Prize.
In late March, ADI CEO Paola Barbarino travelled to St. Paul’s Bay, Malta to give a keynote address to the Empowering Minds: Innovation and Compassion in Dementia Care symposium hosted by the Dementia Care Directorate, Active Ageing and Community Care. This symposium focused on the symbiosis between advocacy and advancement within dementia care and research.
February saw a flurry of dementia-related activity within the European region. Sweden has updated their national dementia strategy from 2018; ADI’s Head of Membership attended a session at the Belgian Senate; as part of their efforts to raise the profile of those living with dementia; ADI CEO Paola Barbarino virtually opened the 14th Panhellenic Conference on Alzheimer's Disease, organized by ADI’s member in Greece, Panhellenic Federation of Alzheimer’s Disease and Related Disorders, and ADI is partaking in the public hearings for the development of the WHO Second European Program of Work.